Correlation Between Sun Life and Spyre Therapeutics

Can any of the company-specific risk be diversified away by investing in both Sun Life and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sun Life and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sun Life Financial and Spyre Therapeutics, you can compare the effects of market volatilities on Sun Life and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sun Life with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sun Life and Spyre Therapeutics.

Diversification Opportunities for Sun Life and Spyre Therapeutics

0.58

Correlation Coefficient

Sun Life  Spyre Therapeutics

Very weak diversification

The 3 months correlation between Sun and Spyre is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Sun Life Financial and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Sun Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sun Life Financial are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Sun Life i.e., Sun Life and Spyre Therapeutics go up and down completely randomly.

Pair Corralation between Sun Life and Spyre Therapeutics

Considering the 90-day investment horizon Sun Life Financial is expected to generate 0.35 times more return on investment than Spyre Therapeutics. However, Sun Life Financial is 2.86 times less risky than Spyre Therapeutics. It trades about -0.02 of its potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.11 per unit of risk. If you would invest  5,890  in Sun Life Financial on December 26, 2024 and sell it today you would lose (128.00) from holding Sun Life Financial or give up 2.17% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Sun Life Financial  vs.  Spyre Therapeutics

Sun Life Financial

Risk-Adjusted Performance

Very Weak

Over the last 90 days Sun Life Financial has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Sun Life is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.

Spyre Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Spyre Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Sun Life and Spyre Therapeutics

The main advantage of trading using opposite Sun Life and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sun Life position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.

The idea behind Sun Life Financial and Spyre Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.